TCEA1 Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes.
Synonyms
GTF2S; TCEA; Tcea1; TF2S; TFIIS.
Gene ID
6917
Swiss Prot
P23193
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
TCEA1
Clonality
Recombinant
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human TCEA1
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
6917
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC402976 20 µg
C17ORF39 (GID4) (NM_024052) Human Over-expression Lysate
Sign In for Pricing
View Details 
![Octahydro-1H-pyrrolo[3,4-b]pyridine-d2 Di-trifluoroacetate](https://cdn.genprice.uk/products/572/8327728995786/imageurl/trc-o236512-25mg.webp)
TRC-O236512-25MG 25 mg
Octahydro-1H-pyrrolo[3,4-b]pyridine-d2 Di-trifluoroacetate
Sign In for Pricing
View Details 
BNC882059-100 1x 100 µL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
